A next-generation, digital Observational Study for SCN2A-related disorders is expected to facilitate:
- Informing clinical researchers how a disease changes over time
- Enabling better endpoint selection to use in clinical trials
- The connection between mutation types and symptoms to facilitate targeted therapies
- Reducing the time it takes to study new medicines in clinical trials
- Speeding up the time to get therapeutics to patients
- The use of data as a placebo (instead of actual patients) in a clinical trial
This study will complement the International SCN2A Natural History and real-world evidence studies for SCN2A-related disorder patients. Become a Ciitizen and help advance research and accelerate treatments by clicking here!
Please note that this is only available in the US however Ciitizen plan to expand globally starting in April.